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Abstract
Background—Red blood cell (RBC) transfusion decreases intermittent hypoxemia (IH) events 
beyond the first week of life. This benefit may be related to improved perfusion to the respiratory 
control network. Perfusion index (PI) is a perfusion measure provided by the pulse oximeter. We 
hypothesized that the benefit in IH after RBC transfusion is associated with a rise in PI. In 
addition, we assessed the value of PI and clinical measures in predicting the effect of RBC 
transfusion on IH.
Study Design and Methods—We prospectively enrolled infants less than 30 weeks gestational 
age. PI and oxygen saturation (SpO2) were monitored with high-resolution pulse oximeters 24 
hours pre and post RBC transfusion. Data was analyzed at three postnatal periods, epoch 1: first 
week of life (1 to 7 days of life), epoch 2: 2 to 4 weeks of life (8 to 28 days of life), and epoch 3: 4 
to 8 weeks of life.
Results—One hundred eighteen transfusions were analyzed. IH measures significantly decreased 
post transfusion in epochs 2 and 3. PI significantly increased after transfusion, but it did not 
correlate with the decrease in IH measures. Mechanical ventilation, fraction of inspired oxygen 
(FiO2), and IH measures influenced the effects on oxygenation.
Conclusions—RBC transfusion improved IH after the first week of life. The benefit in IH did 
not correlate with PI increase after transfusion. Pre transfusion respiratory support and IH 
measures predicted the effect of transfusion on oxygenation.
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INTRODUCTION
Intermittent Hypoxemia (IH), defined as episodic drops in oxygen saturation, is common in 
preterm infants.1–3 The incidence of IH in extremely low gestational age infants changes 
during the first 2 months of life.1,2 There is low IH frequency during the first week of life, 
followed by a progressive increase over weeks 2-3, plateaus around 4 weeks, and decreases 
at weeks 6-8.1,2 Intermittent hypoxemia is associated with both short and long term 
morbidities such as retinopathy of prematurity,2 neurodevelopmental impairment, and late 
death.1,3–5 Red blood cell (RBC) transfusion results in IH improvement, particularly beyond 
the first week of life.1 Perhaps, the main rationale for RBC transfusion in preterm infants is 
improvement in oxygenation.6 There are two proposed mechanisms for beneficial effect of 
RBC transfusion on oxygenation. The first relates to greater cardiovascular stability with 
increased perfusion to the respiratory control network leading to improved central 
respiratory drive and subsequent less IH.1,7–9 The second suggests greater stability of 
oxygenation due to a rise in hematocrit leading to less IH in the presence of apnea.1,10
Perfusion index (PI) is a noninvasive measure of perfusion provided by the bedside pulse 
oximeter. Perfusion index is calculated from the ratio of the pulsatile to non-pulsatile signal 
at the monitoring site.11,12 Perfusion index correlates with superior vena cava flow,13 detects 
critical left heart obstructive disease,14 and patent ductus arteriosus.15,16 Furthermore, 
Kanmaz et al. noted that RBC transfusion is associated with a significant increase in PI and 
suggested that PI may be a useful marker for the need of transfusion.17 Therefore, we 
wanted to assess if the benefit in IH seen after RBC transfusion is associated with a rise in PI 
in preterm infants at different postnatal ages. In addition, we assessed the predictive value of 
PI, hematocrit, mechanical ventilation, fraction of inspired oxygen (FiO2) and IH; in order to 
identify infants who will benefit the most from the RBC transfusion in terms of oxygenation.
MATERIALS AND METHODS
Study Design and Data Collection
This was a prospective cohort study conducted at the University of Kentucky Medical Center 
Neonatal Intensive Care Unit between November 2014 and October 2015. The study was 
approved by the University of Kentucky Institutional Review Board. Infants with gestational 
age (GA) less than 30 weeks were approached in the first week of life and informed consent 
was obtained from parent(s). Infants were then followed and oxygen saturation was 
continuously monitored in the first 2 months of life. Infants who received RBC transfusion 
per the NICU transfusion guidelines were included in the analyses. The following is a 
summary of the local NICU transfusion guidelines: Hematocrit threshold of <35% for 
mechanically ventilated neonates or FiO2 requirement >40%, hematocrit <28% for infants 
on non-invasive respiratory support or FiO2 requirement <40%, and hematocrit <22% for 
neonates on no respiratory support. RBC transfusion at 15ml/kg was administered over a 3 
hour period. Oxygen saturation (SpO2) and PI were monitored using continuous high-
resolution (2s averaging time and 1Hz sampling rate) pulse oximeters (Radical 7: Masimo, 
Irvine, CA, USA). The target oxygen saturation in our unit is 90-95%. Patients were 
continuously monitored for the first 8 weeks of life and data was stored on serial data 
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recorders. Novel programs were utilized to filter (Matlab, Natick, MA, USA) and analyze 
(SAS Institute, Cary, NC, USA) data. Variables related to demographics, weight, respiratory 
measures and medications were collected.
The primary outcome measures for IH were defined as 1) a drop in SpO2 to less than 80% 
for ≥4s and ≤3min duration (IH-SpO2<80) and 2) overall percent time spent with SpO2 
<80% (%time-SpO2<80). The lower limit of 4s duration was based on the previous data by 
Abu Jawdeh et al. and the upper limit of 3 min duration was used to differentiate intermittent 
from sustained hypoxemia.1 Other outcome measures included additional SpO2 thresholds 
of 85% and 90%.
A RBC transfusion was eligible for analysis if no other RBC transfusion was administered 
24 hours pre or post transfusion. We then analyzed changes in IH frequency (IH-SpO2<80, 
IH-SpO2<85, IH-SpO2<90), percent time spent below threshold (%time-SpO2<80, %time-
SpO2<85, %time-SpO2<90), mean PI, and variability of PI during the 24 hours pre and post 
RBC transfusion. Additionally, we determined the associated changes in hematocrit and 
respiratory characteristics.
To account for the effect of postnatal age on IH following RBC transfusion2, the 8-week 
monitoring period was stratified into three epochs and analyzed separately; epoch 1: first 
week of life (1 to 7 days of life), epoch 2: 2 to 4 weeks of life (8 to 28 days of life), and 
epoch 3: 4 to 8 weeks of life.1 In order to assess which preterm infants benefit the most from 
RBC transfusion, we evaluated the predictive value of the following pre RBC transfusion 
variables: PI, hematocrit, mechanical ventilation, FiO2 requirement, and IH primary 
measures.
Statistical Analysis
To compare epochs in Table 1, continuous variables were presented as mean ± standard 
deviation (SD) and categorical variables were expressed as frequencies and percentages. 
Sample means and SDs were also utilized in Figures 2 and 3 to visually compare pre and 
post RBC transfusion values for each epoch. Pearson’s correlations were used to quantify 
associations between changes in different variables. To account for statistical correlation 
arising from repeated measurements, i.e. multiple observations per subject, generalized 
estimating equations with robust standard errors were utilized for inference. Finally, linear 
mixed models with robust standard errors were utilized to obtain results for Table 3, in 
which change in IH measures (IH-SpO2<80 or %time-SpO2<80) after RBC transfusion was 
the outcome of interest. The primary predictors were pre RBC transfusion mechanical 
ventilation, FiO2 requirement, and pre RBC transfusion IH measures. The models also 
controlled for pre RBC transfusion PI and hematocrit. All tests were two-sided at the 5% 
significance level. Analyses were conducted in SAS version 9.4 (SAS Institute, Cary, NC, 
USA).
RESULTS
Fifty preterm infants met criteria for enrollment. Thirty-nine infants received RBC 
transfusions that were eligible for analysis for a total of 118 transfusions (22, 63 and 33 
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RBC transfusions in epochs 1, 2, and 3, respectively). The median (IQR) of eligible 
transfusions were as follows: 2(1-2), 5(3-7) and 8(6-10) for epochs 1, 2, and 3, respectively 
(Table 1). Figure 1 shows the flow diagram for patient enrollment, transfusion eligibility, and 
number of infants who received transfusions during each epoch. There were no significant 
differences in GA, birth weight, gender, and race across all 3 epochs (Table 1). The majority 
of infants required respiratory support, supplemental oxygen and caffeine therapy (Table 1). 
The FiO2 requirement (mean ± standard deviation) increased to 35.2% ±11.6 (p=0.1), 43.7% 
± 19.3 (p=0.9) and 47.8% ± 24.7 (p=0.3) in epochs 1, 2 and 3 respectively but was not 
statistically significant.
Changes in Measures Pre and Post RBC Transfusion
As represented in Figure 2A, there was a statistically significant but minimal increase in 
mean 24 hour PI after RBC transfusion across all epochs. There was no difference in 
variability of PI between pre and post RBC transfusion in all 3 epochs (pre-post: −0.07 
± 0.33, p=0.2; −0.01 ± 0.12, p=0.5; −0.05 ± 0.15, p=0.1 in epochs 1, 2 and 3 respectively). 
In epoch 1, there was no change in IH-SpO2<80 and IH-SpO2<85 post RBC transfusion; 
interestingly, there was a significant increase in IH-SpO2<90 (Figure 3). Overall, %time-
SpO2<80, %time-SpO2<85 and %time-SpO2<90 did not significantly change in epoch 1 
(Figure 3). In epochs 2 and 3, we found a significant decrease in IH-SpO2<80 and IH-
SpO2<85 and no change in IH-SpO2<90 (Figure 3). Overall %time-SpO2<80% and %time-
SpO2<85 improved in epoch 2 and 3 with no changes in %time-SpO2<90. As expected, 
mean hematocrit significantly increased 24 hours after RBC transfusion across all three 
epochs (Figure 2B).
Correlations of Changes Pre and Post RBC Transfusion
There was no significant correlation between changes in PI and IH pre and post RBC 
transfusion in any of the 3 epochs (Table 2). There was no correlation between changes in 
hematocrit and IH pre and post RBC transfusion in epochs 1 and 2 (Table 2). In epoch 3, 
there was a positive correlation between the change in hematocrit and IH measures that was 
statistically significant for %time-SpO2<80 (Table 2).
Factors Associated with the Effect of RBC Transfusion on IH measures
Linear mixed models were utilized to assess factors that influenced the effect of RBC 
transfusion on IH. The models controlled for pre RBC transfusion PI, hematocrit, 
mechanical ventilation, FiO2 requirement and IH-SpO2<80 or %time-SpO2<80. The results 
are presented in Table 3.
DISCUSSION
Our study shows an increase in perfusion (as represented by the rise in PI) after RBC 
transfusion. However, this increase does not correlate with the improvement in oxygenation. 
Consistent with Abu Jawdeh et al.,1 our study shows that IH improved post RBC transfusion 
only beyond the first week of life.2 In addition, our results replicate the lack of benefit in 
oxygenation after RBC transfusion in the first week of life. This study also demonstrates that 
Ibonia et al. Page 4
Transfusion. Author manuscript; available in PMC 2019 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
pre RBC transfusion mechanical ventilation need, FiO2 requirement and IH measures 
influence the effect of RBC transfusions on oxygenation.
Similar to a study by Kanmaz et al.,17 our results show a significant increase in PI post RBC 
transfusion. The increase in PI is minimal and may not be clinically significant. The 
observed increase in PI did not correlate with a decrease in IH measures following RBC 
transfusion. The effect of RBC transfusion on PI may be related to volume expansion. In 
contrast, RBC transfusion effect on IH is likely due to changes in oxygen carrying capacity 
and stabilization of oxygenation.6,10,18
The effect of RBC transfusion on IH varied based on postnatal age. There was significant 
improvement in oxygenation after RBC transfusion in epochs 2 and 3. However, there was 
no significant change in IH measures after RBC transfusion during the first week of life; in 
fact, an increase in IH frequency occurred for IH-SpO2<90. This increase in IH events in 
epoch 1 after transfusion for IH-SpO2<90 reflects the increase in milder events (SpO2 
≥85%); although all trended in the same direction. The etiology of this reproducible lack of 
benefit in oxygenation after RBC transfusion in early postnatal life is unknown, but may be 
influenced by multiple factors. The lack of benefit may be related to the already low 
incidence of IH during this period.1,2 Other factors may include inadequate compensatory 
mechanisms to overcome the changes in blood flow, volume status and blood viscosity 
associated with RBC transfusion during early postnatal life.6,18–20 Furthermore, the higher 
proportions of high-affinity fetal hemoglobin in early postnatal life may have an impact on 
the effect of RBC transfusion on oxygenation.10,20 The lack of benefit in oxygenation after 
RBC transfusion in the first week of life raises important concerns regarding liberal 
transfusion thresholds during early postnatal life and the need to further evaluate any adverse 
respiratory effects in this time period. In addition, studies to further evaluate mechanisms 
and factors that influence the effect of RBC transfusion on IH in the first week of life are 
imperative.
Respiratory support (mechanical ventilation and FiO2) and IH measures influenced the 
effect of RBC transfusions on oxygenation (Table 3). As expected, patients on mechanical 
ventilation benefited more from RBC transfusion compared to extubated infants in epoch 2 
and approached significance in epoch 3. Interestingly, in epoch 1, patients on mechanical 
ventilation had no improvement or worsening in oxygenation after RBC transfusion. We 
speculate the findings seen in the first week of life in ventilated infants may relate to patient 
characteristics including immaturity of compensatory mechanisms, severe lung disease with 
poor pulmonary reserves and subsequent lung fluid overload from RBC transfusion.6,10,20 
Increased FiO2 requirement pre RBC transfusion was associated with a significant decrease 
in IH measures post transfusion during epoch 1. After the first week of life, higher IH 
measures pre RBC transfusion were associated with greater benefit in oxygenation that was 
statistically significant in epoch 2 and approached significance (p=0.053) in epoch 3. Extent 
of FiO2 requirement and IH measures are closely related as FiO2 adjustment is often based 
on oxygen desaturations. Our sample size may not have been large enough to reach 
statistical significance in all epochs; however, FiO2 and IH measures are promising objective 
tools able to guide transfusion management. Overall, the results of the study show that 
postnatal age, along with type of respiratory support and IH measures, influence the effect of 
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RBC transfusion on oxygenation. Further studies to evaluate mechanisms as to how these 
factors influence the effect of RBC transfusion on IH are needed.
Maintaining hematocrit above a certain consensus threshold is the major indication for RBC 
transfusion in NICUs worldwide.21,22 Consistent with previous studies, our results suggest 
that hematocrit alone is a weak predictor of the effect of RBC transfusion on oxygenation.
1,5,7,9,23,24
 Although hematocrit significantly increased post RBC transfusion, the change in 
hematocrit did not correlate with improved oxygenation after RBC transfusion except in 
epoch 3 where a poor correlation was noted (Table 2). We speculate that hematocrits are 
closely followed in the NICU and the levels in our infants may not have been low enough to 
result in significant cardiorespiratory instability.
A limitation to this study is not having evaluated other hemodynamic factors such as blood 
pressure, heart rate, and volume status. We also lack documentation of other neonatal 
morbidities that may have affected PI and oxygenation such as presence of intraventricular 
hemorrhage, patent ductus arteriosus, and sepsis. As our model included multiple variables, 
the current sample size may have lacked sufficient power to reach significance in certain 
epochs. The possible variation in RBC transfusion indications among providers is a 
limitation, but likely minimized by our unit consensus transfusion guidelines.
CONCLUSION
Red blood cell transfusion is associated with decreased IH events after the first week of life. 
The lack of benefit in oxygenation after RBC transfusion in the first week of life is an 
interesting finding now reported twice from two separate cohorts. This finding requires 
further investigation especially after possible worsening in oxygenation reported in this 
study. Our primary aim to assess the value of PI as an indication for RBC transfusion did not 
yield positive findings. We documented factors, other than hematocrit, that should be 
considered before RBC transfusion administration; including mechanical ventilation, FiO2 
requirement and IH measures. Our study is a stepping stone towards larger studies aimed at 
finding objective bedside measures to guide RBC transfusion administration.
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FIGURE 1. 
Flow diagram for patient enrollment and transfusion eligibility
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FIGURE 2. 
Mean PI and Hematocrit levels for all the 3 epochs pre and post RBC transfusion. There was 
a statistically significant increase in the PI (A) and hematocrit (B) after RBC transfusion in 
all the three epochs (*p<0.05). Mean/standard deviation
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FIGURE 3. 
IH events/day and % time below threshold pre and post transfusion. 3A-C: IH-SpO2<80 and 
IH-SpO2<85 decreased in epochs 2 and 3 (*p<0.04) while IH-SpO2<90 increased in epoch 1 
(*p=0.04). 3D-F: % time-SpO2<80 and % time-SpO2<85 decreased in epochs 2 and 3 
(*p<0.04). There was a decrease in % time-SpO2<90 in epochs 2 (p=0.2) and 3 (p=0.3) and 
increase in epoch 1 (p=0.07). Mean/standard deviation
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TABLE 1
Baseline characteristics of enrolled patients among epochs
Epoch 1
n=22
Epoch 2
n=63
Epoch 3
n=33
p value
Gestational age in weeks (n) (Mean ± SD) (22) 25.8 ± 1.3 (62) 25.6 ± 1.3 (33) 25.6 ± 1.2 0.8
Birth weight in grams (n) (Mean ± SD) (22) 807 ± 162 (62) 796 ± 171 (33) 803 ± 179 0.94
Postnatal age in days (n) (Mean ± SD) (22) 4.6 ± 1.6 (62) 18.0 ± 6.4 (33) 43.5 ± 8.9 <0.001
Weight day of transfusion in grams (n) (Mean ± SD) (22) 808 ± 153 (62) 982 ± 247 (33) 1475 ± 434 <0.001
Number of Transfusions Per Patient, Median (Interquartile Range) (22) 2 (1-2) (63) 5 (3-7) (33) 8 (6-10) <0.001
Male, n (%) 15/22 (68%) 36/62 (58%) 21/33 (64%) 0.7
Caucasian, n (%) 17/22 (77%) 53/61 (87%) 27/33 (82%) 0.7
Respiratory Support
 Conventional ventilator, n (%) 18 (86%) 50 (86%) 21 (68%) 0.22
 Non-invasive ventilation, n (%) 3 (14%) 8 (14%) 10 (32%)
 NIPPV, n (%) 2 (10%) 6 (10%) 7 (23%)
 CPAP, n (%) 1 (5%) 2 (3%) 3 (10%)
 Missing data for type of respiratory support, n (%) 1 (5%) 5 (8%) 2 (6%)
Supplemental oxygen, n (%) 19/21 (90%) 54/58 (93%) 29/31 (94%) 0.92
Pre RBC transfusion FiO2 (n) (Mean ± SD) (21) 30.0 ± 9.3 (59) 42.7 ± 21.0 (31) 44.8 ± 20.8 <0.001
Caffeine, n (%) 21/22 (95%) 62/62 (100%) 31/33 (94%) 0.55
aSD, standard deviation;
bNIPPV, nasal intermittent positive pressure ventilation;
cCPAP, continuous positive airway pressure; p for mean difference;
Transfusion. Author manuscript; available in PMC 2019 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Ibonia et al. Page 13
TA
B
LE
 2
Co
rre
la
tio
ns
 o
f c
ha
ng
es
 in
 P
I, 
H
em
at
oc
rit
 a
nd
 IH
Ep
oc
h
ΔI
H
 E
ve
n
ts
 <
 8
0%
Δ%
tim
e <
 8
0%
r
p 
v
a
lu
e
r
p 
v
a
lu
e
Δ 
Pe
rfu
sio
n 
In
de
x
1
−
0.
05
0.
46
−
0.
18
0.
61
2
0.
18
0.
13
0.
14
0.
38
3
−
0.
16
0.
22
0.
07
0.
51
Δ 
H
em
at
oc
rit
1
0.
1
0.
33
−
0.
03
0.
88
2
−
0.
11
0.
37
−
0.
05
0.
86
3
0.
27
1
0.
08
0.
32
2
0.
02
a Δ
 re
pr
es
en
ts 
ch
an
ge
 in
 v
al
ue
: p
os
t R
BC
 tr
an
sf
us
io
n 
- p
re
 R
BC
 tr
an
sf
us
io
n.
b r
 =
 c
o
rr
el
at
io
n 
co
ef
fic
ie
nt
Transfusion. Author manuscript; available in PMC 2019 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Ibonia et al. Page 14
TA
B
LE
 3
Pr
ed
ic
to
rs
 o
f t
he
 e
ffe
ct
 o
f R
BC
 tr
an
sf
us
io
ns
 o
n 
IH
.
Pr
ed
ic
to
r
O
ut
co
m
e M
ea
su
re
Ep
oc
h 
1
Ep
oc
h 
2
Ep
oc
h 
3
C
oe
ffi
ci
en
t
(95
%
 C
I)
p
C
oe
ffi
ci
en
t
95
%
 C
I
p
C
oe
ffi
ci
en
t
95
%
 C
I
p
Pe
rfu
sio
n 
In
de
x
IH
-S
pO
2<
80
−
26
.9
−
74
.6
20
.7
0.
22
−
14
.8
−
10
3.
6
74
.1
0.
73
99
.4
−
75
27
3.
7
0.
20
%
tim
e-
Sp
O
2<
80
−
1.
20
−
3.
00
0.
58
0.
16
−
0.
50
−
2.
96
1.
99
0.
69
1.
86
−
2.
95
6.
67
0.
40
H
em
at
oc
rit
IH
-S
pO
2<
80
−
0.
33
−
9.
1
8.
4
0.
93
12
.7
−
2.
5
27
.9
0.
10
−
5.
56
−
14
.3
9
3.
27
0.
20
%
tim
e-
Sp
O
2<
80
−
0.
03
−
0.
15
0.
09
0.
60
0.
40
0.
12
0.
72
0.
01
−
0.
14
−
0.
49
0.
20
0.
40
M
ec
ha
ni
ca
l v
en
til
at
io
n
IH
-S
pO
2<
80
35
−
4.
4
74
.5
0.
07
−
60
.8
14
0
18
.5
0.
13
−
84
.1
−
17
3.
7
5.
4
0.
06
%
tim
e-
Sp
O
2<
80
2.
40
0.
46
4.
48
0.
02
−
2.
30
−
4.
69
−
0.
03
0.
05
0
−
2.
30
−
5.
52
0.
73
0.
10
Fi
O
2
IH
-S
pO
2<
80
−
1.
52
−
3.
01
−
0.
03
0.
04
7
−
0.
82
−
1.
7
0.
05
0.
06
2.
01
−
0.
23
4.
24
0.
07
%
tim
e-
Sp
O
2<
80
−
0.
10
−
0.
14
−
0.
04
0.
00
2
−
0.
04
−
0.
08
0.
00
0.
07
0.
07
−
0.
01
0.
15
0.
09
IH
-S
pO
2<
80
IH
-S
pO
2<
80
−
0.
49
−
1.
1
0.
12
0.
10
−
0.
38
−
0.
8
0.
04
0.
07
−
0.
24
−
0.
49
0.
00
3
0.
05
3
%
tim
e-
Sp
O
2<
80
%
tim
e-
Sp
O
2<
80
0.
55
−
0.
19
1.
29
0.
13
−
0.
29
−
0.
52
−
0.
06
0.
02
−
0.
28
−
0.
65
0.
08
0.
10
Transfusion. Author manuscript; available in PMC 2019 November 01.
